A Randomized Trial of Adjuvant Chemotherapy with Uracil–Tegafur for Adenocarcinoma of the Lung
Harubumi Kato(Tokyo Medical University), Mitsuo Ohta, Masahiro Tsuboi(National Cancer Center Hospital East), Hiromi Wada(Kyoto University), Nobuyuki Hamajima(Nagoya University), Hirohito Tada(Osaka City General Hospital), Noriaki Tsubota(Akashi Medical Center), Enjô Hata(Mitsui Memorial Hospital), Yoh Watanabe(Kanazawa University), Yukito Ichinose(National Hospital Organization Kyushu Cancer Center), Morio Ohta
Cited by 839
Related Papers
Gefitinib or Carboplatin–Paclitaxel in Pulmonary Adenocarcinoma
|New England Journal of Medicine|2009|8.2k
International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society International Multidisciplinary Classification of Lung Adenocarcinoma
|Journal of Thoracic Oncology|2011|4.8k
Osimertinib in Resected <i>EGFR</i> -Mutated Non–Small-Cell Lung Cancer
|New England Journal of Medicine|2020|1.7k
Segmentectomy versus lobectomy in small-sized peripheral non-small-cell lung cancer (JCOG0802/WJOG4607L): a multicentre, open-label, phase 3, randomised, controlled, non-inferiority trial
|The Lancet|2022|1.6k
Perioperative Pembrolizumab for Early-Stage Non–Small-Cell Lung Cancer
|New England Journal of Medicine|2023|1k